Cardiff Park Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.59M Buy
10,601
+426
+4% +$99.2K 0.21% 68
2025
Q4
$2.11M Sell
10,175
-71
-0.7% -$14K 0.17% 72
2025
Q3
$1.9M Buy
10,246
+96
+0.9% +$16.4K 0.15% 81
2025
Q2
$1.55M Buy
10,150
+37
+0.4% +$5.69K 0.13% 84
2025
Q1
$1.68M Sell
10,113
-32
-0.3% -$5.01K 0.16% 71
2024
Q4
$1.47M Sell
10,145
-43
-0.4% -$6.66K 0.14% 80
2024
Q3
$1.65M Buy
10,188
+23
+0.2% +$3.67K 0.15% 74
2024
Q2
$1.49M Sell
10,165
-1
-0% -$149 0.14% 75
2024
Q1
$1.61M Buy
10,166
+31
+0.3% +$4.93K 0.15% 74
2023
Q4
$1.59M Sell
10,135
-756
-7% -$116K 0.18% 68
2023
Q3
$1.7M Buy
10,891
+20
+0.2% +$3.3K 0.21% 61
2023
Q2
$1.8M Sell
10,871
-35
-0.3% -$5.65K 0.22% 61
2023
Q1
$1.69M Sell
10,906
-44
-0.4% -$7.11K 0.22% 60
2022
Q4
$1.93M Sell
10,950
-404
-4% -$69.8K 0.27% 55
2022
Q3
$1.85M Buy
11,354
+1,477
+15% +$250K 0.29% 52
2022
Q2
$1.75M Buy
9,877
+219
+2% +$39K 0.27% 52
2022
Q1
$1.71M Sell
9,658
-20
-0.2% -$3.4K 0.24% 49
2021
Q4
$1.66M Buy
+9,678
New +$1.58M 0.22% 53

Other funds holding JNJ

Cardiff Park Advisors's JNJ Position: Q1 2026 in Review

Cardiff Park Advisors increased its Johnson & Johnson (JNJ) stake by 4.2% in Q1 2026, buying an estimated $99.2K and bringing the position to 10,601 shares worth $2.59M. The position accounts for 0.21% of the portfolio, ranked #68.

Cardiff Park Advisors first reported a position in JNJ in Q4 2021 and has held it in 18 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Cardiff Park Advisors held 10,601 shares of Johnson & Johnson worth $2.59M as of Q1 2026.
  • Cardiff Park Advisors bought 426 Johnson & Johnson shares in Q1 2026, an estimated $99.2K.
  • Johnson & Johnson made up 0.21% of Cardiff Park Advisors's portfolio in Q1 2026, its #68 holding.
  • Cardiff Park Advisors first reported a position in Johnson & Johnson in Q4 2021 and has held it in 18 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Cardiff Park Advisors's 13F filing for Q1 2026, filed 15 May 2026.